MarketCap
Facebook
X
Telegram
Catalent EV - Enterprise Value | CTLT
Annual EV - Enterprise Value Catalent
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.7 B | 12.6 B | 21.1 B | 25.5 B | 18.9 B | 11.7 B | 7.13 B | 7.58 B | 5.69 B | 5.35 B | 5.48 B | 3.25 B | 3.35 B | -205 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.5 B | -205 M | 10.3 B |
EV - Enterprise Value of other stocks in the Drug manufacturers industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cronos Group
CRON
|
-1.35 M | $ 3.26 | 0.62 % | $ 1.25 B |  Canada |
 |
Evoke Pharma
EVOK
|
-3.12 M | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
560 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-974 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
6.79 M | - | 7.5 % | $ 6.35 M | USA |
 |
China Pharma Holdings
CPHI
|
10.7 M | $ 0.84 | 1.18 % | $ 3.6 M |  China |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
28.5 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
737 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
25.3 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
197 M | - | - | $ 142 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
756 M | - | - | $ 2.06 B |  France |
 |
Athenex
ATNX
|
209 M | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
126 M | $ 6.75 | 3.53 % | $ 100 M | USA |
 |
DURECT Corporation
DRRX
|
-11 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
457 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
-710 M | - | - | $ 28.9 M |  Irlanda |
 |
Rockwell Medical
RMTI
|
43.3 M | $ 7.99 | 0.31 % | $ 287 M | USA |
 |
Jupiter Wellness
JUPW
|
3.7 M | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
467 M | $ 9.05 | 0.11 % | $ 583 M | USA |
 |
Lannett Company
LCI
|
671 M | - | 1.15 % | $ 7.11 M | USA |
 |
Sundial Growers
SNDL
|
331 M | $ 1.41 | 4.41 % | $ 364 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-80.1 M | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
238 M | - | - | $ 150 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-22.6 M | - | - | $ 55.5 M | USA |
 |
Radius Health
RDUS
|
715 M | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
396 B | - | 1.64 % | $ 400 M | USA |
 |
Tilray
TLRY
|
4.01 B | $ 4.53 | 0.22 % | $ 4.03 B | Canada |
 |
Recro Pharma
REPH
|
220 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
84.7 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
75 M | - | -27.8 % | $ 2.56 M | USA |
 |
Harrow Health
HROW
|
2.21 B | $ 38.26 | 5.63 % | $ 1.41 B | USA |
 |
Zomedica Corp.
ZOM
|
2.62 M | - | -0.21 % | $ 98 M | USA |
 |
Tricida
TCDA
|
555 M | - | - | $ 3.25 M | USA |
 |
Bausch Health Companies
BHC
|
26.7 B | $ 6.76 | 5.56 % | $ 2.51 B | Canada |
 |
Emergent BioSolutions
EBS
|
1.04 B | $ 6.23 | 3.86 % | $ 333 M | USA |
 |
Organogenesis Holdings
ORGO
|
408 M | $ 1.64 | 2.45 % | $ 208 M | USA |
 |
OrganiGram Holdings
OGI
|
146 M | $ 1.17 | 0.42 % | $ 111 M | Canada |
 |
Veru
VERU
|
80.7 M | $ 2.65 | 2.23 % | $ 38.8 M | USA |
 |
Perrigo Company plc
PRGO
|
7.03 B | $ 14.27 | 0.42 % | $ 1.98 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
10.3 M | $ 1.32 | 2.33 % | $ 2.22 M | USA |
 |
Relmada Therapeutics
RLMD
|
251 M | $ 4.37 | 1.79 % | $ 173 M | USA |
 |
SCYNEXIS
SCYX
|
26.3 M | $ 5.35 | 2.39 % | $ 267 M | USA |
 |
TherapeuticsMD
TXMD
|
26.3 M | $ 2.24 | 0.22 % | $ 25.9 M | USA |
 |
Solid Biosciences
SLDB
|
616 M | $ 10.42 | 1.31 % | $ 912 M | USA |
 |
Viatris
VTRS
|
21.2 B | $ 16.94 | 2.77 % | $ 19.5 B | USA |
 |
Canopy Growth Corporation
CGC
|
349 M | $ 0.97 | 0.5 % | $ 289 M | Canada |
 |
cbdMD
YCBD
|
4.51 M | $ 0.48 | 0.8 % | $ 1.93 M | USA |
 |
ProPhase Labs
PRPH
|
56.3 M | - | - | $ 5.07 M | USA |
 |
Aurora Cannabis
ACB
|
330 M | $ 3.89 | 0.74 % | $ 213 M | Canada |